General Information of the Compound
Compound ID
CP0397695
Compound Name
[2-chloro-4-(3-methylpyrazol-1-yl)phenyl]-(2,3,4,5-tetrahydro-1-benzazepin-1-yl)methanone
    Show/Hide
Structure
Formula
C21H20ClN3O
Molecular Weight
365.864
Canonical SMILES
Cc1ccn(n1)-c1ccc(C(=O)N2CCCCc3ccccc23)c(Cl)c1
    Show/Hide
InChI
InChI=1S/C21H20ClN3O/c1-15-11-13-25(23-15)17-9-10-18(19(22)14-17)21(26)24-12-5-4-7-16-6-2-3-8-20(16)24/h2-3,6,8-11,13-14H,4-5,7,12H2,1H3
    Show/Hide
InChIKey
DAJTYMRNVHIRNN-UHFFFAOYSA-N
Physicochemical Property
logP
4.81722
Rotatable Bonds
2
Heavy Atom Count
26
Polar Areas
38.13
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10570880
SID: 15598929
ChEMBL ID
CHEMBL136109
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01648, Vasopressin V2 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS